Teva Pharmaceuticals U
Closed portfolio with an early-phase archive tilt
According to ClinicalTrials.gov-derived indexes, Teva Pharmaceuticals U sits in the top decile of US sponsors by registered trial count (#772 of 15,742 sponsors by registered trial count).
Teva Pharmaceuticals U: 19 sponsored US clinical trials, none currently recruiting.
Teva Pharmaceuticals U sponsors 19 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 19 completed. 1 of these trials are in Phase 3-4 (later-stage) and 18 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Healthy, with 17 trials.
Top-decile sponsor footprint
Teva Pharmaceuticals U ranks in the top decile of sponsors by registered trial count (#772 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
19 of 19 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (100.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Indexed trials (enrollment closed)
19 total, page 1 of 1
Study to Compare Efficacy and Safety of TEV-45779 With XOLAIR (Omalizumab) in Adults With Chronic Idiopathic Urticaria
NCT04976192
Norethindrone/Ethinyl Estradiol 0.4 mg/35 Mcg Chewable Tablets Under Fasting Conditions
NCT01340625
Divalproex Sodium 500 mg Extended Release Tablets Under Non-Fasting Conditions
NCT00974012
Drospirenone/Ethinyl Estradiol (3 mg/0.02 mg) Tablets Under Non-Fasting Conditions
NCT01182207
10 mg Donepezil Hydrochloride Orally Disintegrating Tablets Under Fasting Conditions.
NCT01260922
Alprazolam Extended-Release 3mg Tablets Bioequivalence Study Under Non-fasting Conditions
NCT00830024
Valacyclovir 1000 mg Tablet Under Fasting Conditions
NCT01149499
Cefadroxil 500 mg Capsules Under Fasting Conditions
NCT00834275
Cefadroxil 500 mg Capsules in Normal Healthy Non-Smoking Male and Female Subjects.
NCT00835081
Lansoprazole 30 mg DR Capsule Fasting Study
NCT01045967
Cefprozil for Oral Suspension 250 mg/5 mL, Fasting
NCT00835614
Cilostazol 50 mg Tablets Under Fasting Conditions
NCT00839930
Cilostazol 100 mg Tablet Formulations Under Fasting Conditions
NCT00838630
Azithromycin 600 Mg Tablets, Fasting
NCT00834756
Clarithromycin 500 mg Extended Release Tablets Under Fasting Conditions
NCT00840411
Clarithromycin 500 mg Extended Release Tablets Under Non-Fasting Conditions.
NCT00840216
Azithromycin 600 Mg Tablets, Fed
NCT00834132
Fexofenadine Hydrochloride 180 mg Tablets Under Fasting Conditions
NCT00835276
Terbinafine HCl 250 mg Tablet Formulations Under Non-Fasting Conditions
NCT00833664
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 18 |
| Phase 3 | 1 |
Therapeutic Areas
How the Teva Pharmaceuticals U early-phase archive is shaped
19 indexed studies, none listed as recruiting (0% open); 19 completed (100%).
Phase mix: 1 late (III/IV) vs 18 early (I/II) (early-phase heavy).
Top condition: Healthy (17 trials), 2 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Teva Pharmaceuticals U: archived-pipeline peers nationwide
Peers matched on 19 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Teva Pharmaceuticals U sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 19 archived trials
- Almirall, S.A. · 19 trials · 5% recruiting
- Bastyr University · 19 trials · 11% recruiting
- Church & Dwight Company · 19 trials · 0% recruiting
- Cordis US · 19 trials · 5% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Teva Pharmaceuticals U page
19 registered trials is a research-attention snapshot, not an endorsement of Teva Pharmaceuticals U or any single study.
- None of Teva Pharmaceuticals U's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Healthy is the condition Teva Pharmaceuticals U studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Healthy trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Teva Pharmaceuticals U pipeline card: 19 registered trials from official public datasets.Report a data error.